These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 25034605)

  • 1. Wnt modulators in the aqueous humor are associated with outer retinal damage severity in patients with neovascular age-related macular degeneration.
    Park KH; Choi AJ; Yoon J; Lim D; Woo SJ; Park SJ; Kim HC; Chung H
    Invest Ophthalmol Vis Sci; 2014 Jul; 55(9):5522-30. PubMed ID: 25034605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neovascular age-related macular degeneration: intraocular cytokines and growth factors and the influence of therapy with ranibizumab.
    Funk M; Karl D; Georgopoulos M; Benesch T; Sacu S; Polak K; Zlabinger GJ; Schmidt-Erfurth U
    Ophthalmology; 2009 Dec; 116(12):2393-9. PubMed ID: 19815292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aqueous humor levels of vascular endothelial growth factor before and after intravitreal bevacizumab in type 3 versus type 1 and 2 neovascularization. A prospective, case-control study.
    dell'Omo R; Cassetta M; dell'Omo E; di Salvatore A; Hughes JM; Aceto F; Porcellini A; Costagliola C
    Am J Ophthalmol; 2012 Jan; 153(1):155-61.e2. PubMed ID: 21861975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased Levels of Dickkopf 3 in the Aqueous Humor of Patients With Diabetic Macular Edema.
    Ji B; Lim D; Kim J; Kim HC; Chung H
    Invest Ophthalmol Vis Sci; 2016 Apr; 57(4):2296-304. PubMed ID: 27127928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Intraocular Cytokine Profile and Therapeutic Response in Persistent Neovascular Age-Related Macular Degeneration.
    Rezar-Dreindl S; Sacu S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Weigert G; Schmidt-Erfurth U
    Invest Ophthalmol Vis Sci; 2016 Aug; 57(10):4144-50. PubMed ID: 27537264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between foveal microstructure and visual outcome in age-related macular degeneration.
    Shin HJ; Chung H; Kim HC
    Retina; 2011 Sep; 31(8):1627-36. PubMed ID: 21606888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variable response of vascularized pigment epithelial detachments to ranibizumab based on lesion subtypes, including polypoidal choroidal vasculopathy.
    Inoue M; Arakawa A; Yamane S; Kadonosono K
    Retina; 2013 May; 33(5):990-7. PubMed ID: 23446653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor in patients with exudative age-related macular degeneration treated with ranibizumab.
    Muether PS; Hermann MM; Viebahn U; Kirchhof B; Fauser S
    Ophthalmology; 2012 Oct; 119(10):2082-6. PubMed ID: 22920670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with amd after bevacizumab treatment.
    Roh MI; Kim HS; Song JH; Lim JB; Koh HJ; Kwon OW
    Retina; 2009 Apr; 29(4):523-9. PubMed ID: 19262441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in aqueous vascular endothelial growth factor and pigment epithelial-derived factor levels following intravitreal bevacizumab injections for choroidal neovascularization secondary to age-related macular degeneration or pathologic myopia.
    Chan WM; Lai TY; Chan KP; Li H; Liu DT; Lam DS; Pang CP
    Retina; 2008 Oct; 28(9):1308-13. PubMed ID: 18728623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subfoveal choroidal thickness after ranibizumab therapy for neovascular age-related macular degeneration: 12-month results.
    Yamazaki T; Koizumi H; Yamagishi T; Kinoshita S
    Ophthalmology; 2012 Aug; 119(8):1621-7. PubMed ID: 22551738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined fluorescein angiography and spectral-domain optical coherence tomography imaging of classic choroidal neovascularization secondary to age-related macular degeneration before and after intravitreal ranibizumab injections.
    Coscas F; Querques G; Forte R; Terrada C; Coscas G; Souied EH
    Retina; 2012 Jun; 32(6):1069-76. PubMed ID: 22466476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration.
    Goff MJ; Johnson RN; McDonald HR; Ai E; Jumper JM; Fu A
    Retina; 2007; 27(4):432-8. PubMed ID: 17420694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGF-β concentrations and activity are down-regulated in the aqueous humor of patients with neovascular age-related macular degeneration.
    Tosi GM; Neri G; Caldi E; Fusco F; Bacci T; Tarantello A; Nuti E; Marigliani D; Baiocchi S; Traversi C; Barbarino M; Eandi CM; Parolini B; Mundo L; Santucci A; Orlandini M; Galvagni F
    Sci Rep; 2018 May; 8(1):8053. PubMed ID: 29795291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term stability of vascular endothelial growth factor suppression time under ranibizumab treatment in age-related macular degeneration.
    Muether PS; Hermann MM; Dröge K; Kirchhof B; Fauser S
    Am J Ophthalmol; 2013 Nov; 156(5):989-993.e2. PubMed ID: 23938122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal functional changes measured by microperimetry in neovascular age-related macular degeneration treated with ranibizumab.
    Cho HJ; Kim CG; Yoo SJ; Cho SW; Lee DW; Kim JW; Lee JH
    Am J Ophthalmol; 2013 Jan; 155(1):118-126.e1. PubMed ID: 23022163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of intraocular vascular endothelial growth factor during aflibercept treatment of age-related macular degeneration.
    Fauser S; Schwabecker V; Muether PS
    Am J Ophthalmol; 2014 Sep; 158(3):532-6. PubMed ID: 24879948
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine and Chemokine Profile Changes in Patients with Neovascular Age-Related Macular Degeneration After Intravitreal Ranibizumab Injection for Choroidal Neovascularization.
    Sun T; Wei Q; Gao P; Zhang Y; Peng Q
    Drug Des Devel Ther; 2021; 15():2457-2467. PubMed ID: 34140764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aqueous humour proteins and treatment outcomes of anti-VEGF therapy in neovascular age-related macular degeneration.
    Arai Y; Takahashi H; Inoda S; Tan X; Sakamoto S; Inoue Y; Fujino Y; Kawashima H; Yanagi Y
    PLoS One; 2020; 15(3):e0229342. PubMed ID: 32155173
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
    Lim JW
    Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.